Hypophosphatemia: an update on its etiology and treatment - PubMed (original) (raw)
Review
Hypophosphatemia: an update on its etiology and treatment
André Gaasbeek et al. Am J Med. 2005 Oct.
Abstract
Phosphate plays a key role in several biological processes. In recent years, new insights have been obtained into the regulation of the phosphate metabolism, including a growing amount of evidence suggesting that factors other than parathyroid hormone (PTH) and vitamin D are involved in maintaining the phosphate balance. A new class of phosphate-regulating factors, the so-called "phosphatonins," have been shown to be important in phosphate-wasting diseases. However, the role of the phosphatonins in the normal human homeostasis remains to be established. The incidence of hypophosphatemia in selected patient series can be more than 20%, with clinical sequelae ranging from mild to life threatening. Only when combined with phosphate depletion does hypophosphatemia become clinically significant. The factors that are involved in the phosphate homeostasis, the pathophysiology, the relevance in patient care, the clinical manifestations, and an appropriate management of phosphate depletion are discussed in this review.
Comment in
- Hypophosphatemia: diagnostic significance in Legionnaires' disease.
Cunha BA. Cunha BA. Am J Med. 2006 Jul;119(7):e5-6. doi: 10.1016/j.amjmed.2005.11.026. Am J Med. 2006. PMID: 16828618 No abstract available. - Referencing retracted articles.
Emmett M. Emmett M. Am J Med. 2006 Jul;119(7):e7. doi: 10.1016/j.amjmed.2005.11.023. Am J Med. 2006. PMID: 16828619 No abstract available.
Similar articles
- Regulation of phosphate homeostasis in infants, children, and adolescents, and the role of phosphatonins in this process.
Garabedian M. Garabedian M. Curr Opin Pediatr. 2007 Aug;19(4):488-91. doi: 10.1097/MOP.0b013e328270b902. Curr Opin Pediatr. 2007. PMID: 17630616 Review. - The phosphatonins and the regulation of phosphate homeostasis.
Kumar R. Kumar R. Ann Endocrinol (Paris). 2006 Apr;67(2):142-6. doi: 10.1016/s0003-4266(06)72570-7. Ann Endocrinol (Paris). 2006. PMID: 16639365 No abstract available. - Renal phosphate handling in human--what can we learn from hereditary hypophosphataemias?
Amatschek S, Haller M, Oberbauer R. Amatschek S, et al. Eur J Clin Invest. 2010 Jun;40(6):552-60. doi: 10.1111/j.1365-2362.2010.02286.x. Epub 2010 Apr 14. Eur J Clin Invest. 2010. PMID: 20412291 Review. - Hepatic surgery-related hypophosphatemia.
Datta HK, Malik M, Neely RD. Datta HK, et al. Clin Chim Acta. 2007 May 1;380(1-2):13-23. doi: 10.1016/j.cca.2007.01.027. Epub 2007 Feb 2. Clin Chim Acta. 2007. PMID: 17349987 Review. - Phosphate wasting disorders in adults.
Marcucci G, Masi L, Ferrarì S, Haffner D, Javaid MK, Kamenický P, Reginster JY, Rizzoli R, Brandi ML. Marcucci G, et al. Osteoporos Int. 2018 Nov;29(11):2369-2387. doi: 10.1007/s00198-018-4618-2. Epub 2018 Jul 16. Osteoporos Int. 2018. PMID: 30014155 Review.
Cited by
- Severe hypophosphatemia induced by excessive production of FGF23 in acute hepatitis: from bedside to bench.
Hamroun A, Boukrout N, Cauffiez C, Fellah S, Van der Hauwaert C, Pottier N, Mentaverri R, Zaworski J, Gnemmi V, Gibier JB, Letavernier E, Louvet A, Provôt F, Lenain R, Maanaoui M, Glowacki F, Lionet A. Hamroun A, et al. Clin Kidney J. 2024 Oct 9;17(11):sfae307. doi: 10.1093/ckj/sfae307. eCollection 2024 Nov. Clin Kidney J. 2024. PMID: 39525686 Free PMC article. - PTH like substance secreting mesenchymal tumor causing oncogenic osteomalacia; unravelling the difficulties in localization - A report of 2 cases.
Jijulal CU, Sreedharan S, Naveen P G, Surendran S, Patinharayil G, Fazil V V M, K V N, Sudhan S R. Jijulal CU, et al. J Orthop. 2024 Jun 26;58:123-127. doi: 10.1016/j.jor.2024.06.034. eCollection 2024 Dec. J Orthop. 2024. PMID: 39114427 - The Intricacies of Renal Phosphate Reabsorption-An Overview.
Walker V. Walker V. Int J Mol Sci. 2024 Apr 25;25(9):4684. doi: 10.3390/ijms25094684. Int J Mol Sci. 2024. PMID: 38731904 Free PMC article. Review. - Nomogram for predicting early hypophosphatemia in term infants.
Tao W, Zhan S, Shen Y, Zhao T, Li F, Gao M, Yang T, Yu J. Tao W, et al. BMC Pediatr. 2024 Apr 16;24(1):255. doi: 10.1186/s12887-024-04737-8. BMC Pediatr. 2024. PMID: 38627752 Free PMC article. - A Case of Intractable Hypophosphatemia in a Patient with Guillain-Barré Syndrome and Encephalitis after SARS-CoV-2 Infection.
Zheng Y, Hou Y, Qi M, Zhang Y, Han C, Sun H, Li J. Zheng Y, et al. Endocr Metab Immune Disord Drug Targets. 2024;24(11):1346-1350. doi: 10.2174/0118715303261924231117055702. Endocr Metab Immune Disord Drug Targets. 2024. PMID: 38314683
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources